Corporate Shogun
- Intent: A multipurpose vaccine for a number of extremely lethal diseases.
- Image Source: Artist Credit
- Permissions: Not Applicable
- Primary Source: Not Applicable
- Name: MultiPurpose Aerosol Vaccine (MPAV)
- Manufacturer: Nakaioma Medical
- Affiliation:
- Market Status: Closed-Market
- Modularity: Not Applicable
- Production: Mass-Produced
- Material: Aerosol Combined Virus Cells
- Classification: Drug
- Method of Consumption: Inhalation, two doses required
- Average Life: Indefinitely
- Nutritional Value/Allergies/Side Effects/ Purpose: Immunization against listed viruses, side effects may include sore throat, mild fever.
- Krytos Virus
- Nebellia
- Vira-606
- Fear Virus
- Rooze Disease
- Blue Shadow Virus
- Xenovirus Prime
- Influenza Necrosi
- Brain Rot
- Nine-in-One: Capable of immunizing an individual from nine different viruses, the MPAV is a breakthrough in vaccination production methods. This saves user costs by an immeasurable amount, as now instead of having to buy ten separate vaccines, only one is required. In the same logic, it also makes administering vaccines for large populations significantly easier, as now citizens only have to come in for two doses of a single vaccine.
- Two Doses: As the MPAV utilizes a dead variant of each virus, as living ones were deemed too dangerous to be used on a large scale. Two doses of the vaccine is required to fully immunize an individual and it is advised by Nakaioma Medical that they be taken no longer than a week apart. Requiring people to return to their local distribution center for a second dose within a week from the time of their first dose.
The MultiPurpose Aerosol Vaccine (MPAV) is a vaccine developed by Nakaioma Medical's prestigious Biotechnologies division as per a government contract from the Lords of the Sith. Designed to provide lifetime immunity from several different viruses, a number of which are considered as bioweapons, the MPAV was produced in secret shortly after the contract was released, due to varying potential geopolitical issues that stem from providing a vaccine for citizens in Sith space. Ordered from the NAKAIOMA board itself, the MPAV is being seen by many within the conglomerate as its first step into the galactic northeast in several centuries, truth being lended to that theory as one of Nakaioma Medical's top experts in the field, Shinzo Kapoa was assigned to lead the project, re-stationed from across the galaxy to speed up its development. Having rolled out of production quicker than other NKMedical vaccines, it has nevertheless passed all of the usual tests.
Coming in the form of a thin white pen which holds a container where the combined fine aerosol particles that comprise the preventive medicine is stored, the vaccine is given via this aerosol form due to the many benefits that come with such delivery, including quicker entry into the bloodstream without the hassle and discomfort of an injection, and it is administered by two shots up each of the individual's nostrils. Upon inhalation, the vaccine will enter the person's airway and make its way to the lungs, which is where it will find its way throughout the person's circulatory and respiratory system.
Due to the virality and aggressiveness of each of the individual viruses targeted by the vaccine, NKMedical was forced after several attempts to tame live variants of the viruses to use dead variants, this was a decision based on patient safety, as the chances of even a singular actual infection by using live variants was too great for the MPAV to be distributed on a large scale. And although this guarantees that no infections will accidentally occur, it does mean that two doses will be required instead of one, meaning patients will find it necessary to return to their distribution center within a week in-order to get their second doses. The vaccine itself was produced by running each of the dead virus variants into a sophisticated macromolecular processor and 'combining' them into a single sampling ground for which the body's immune system will be able to get experience with each individual virus by taking distinct parts from each.
Last edited:
